Harmony Biosciences Holdings, Inc.

S&P 500

HRMY/Healthcare · Biotechnology/NASDAQ

Stock Price

$34.13

Stock Price$34.13P/E13.4MCap1.9BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

HRMY does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company focused on the development and commercialization of therapies for neurological disorders. Its lead product, WAKIX, is a molecule with a novel mechanism of action that increases histamine signaling in the brain by binding to H3 receptors, primarily targeting conditions such as narcolepsy and cataplexy. The company operates in the health technology sector, specifically within pharmaceuticals, providing treatments that address unmet needs in sleep-wake disorders and related neurological conditions. WAKIX has received approvals for expanded indications, including cataplexy in pediatric patients, broadening its therapeutic reach. Harmony Biosciences Holdings, Inc. emphasizes innovative solutions in this specialized market, supporting patients through targeted pharmacotherapies. Founded in 2017 and headquartered in Plymouth Meeting, Pennsylvania, the company plays a key role in advancing treatments for rare and debilitating neurological diseases.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$25.52 - $40.87

Earnings & Profitability

HRMY earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

HRMY Dividend Calculator

Number of Shares

Total Investment

$3,413.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is HRMY's current dividend yield?

Harmony Biosciences Holdings, Inc. (HRMY) currently has a dividend yield of 0.00%, based on a stock price of $34.13 and an annual dividend of $0.00.

When is HRMY's next dividend payment date?

HRMY's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does HRMY pay in dividends per year?

Harmony Biosciences Holdings, Inc. pays dividends unknown. Annual dividend data is not yet available.

Has HRMY been increasing its dividend?

Harmony Biosciences Holdings, Inc. has grown its dividend at a 5-year CAGR of —.

Is HRMY's dividend safe?

Harmony Biosciences Holdings, Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is HRMY's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Harmony Biosciences Holdings, Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track HRMY Dividends with OnlyDividends

What will HRMY actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.